AJMC-Oncology

Evidence-Based #Oncology. Bringing together perspectives of 20,000+ cancer care #providers, #payers, #policymakers, #patients, and researchers in #cancer care.

[OneOncology @OneOncology]

Tina Basenese @asteracancer, and vice chair of OneOncology's palliative care committee, authored this piece in @EBOncology detailing 6 strategies to advance and scale palliative care.
⤵ Read the full article. ⤵
https://t.co/9mNmOlYBKh

[OneOncology @OneOncology]

OneOncology and @TNOncology experts are authors on this @EBOncology article examining 5 key drivers of participation in @CMSinnovates Enhancing Oncology Model and how CMMI could improve the low participation in this or future models.
https://t.co/6Qj8ImUIYG

[Ryan Flinn @RS_Flinn]

I've been doing some freelance reporting on how manufacturing delays with CAR-Ts can lead clinicians to look for other options - one physician calls these delays a "wait list mortality" - https://t.co/XFhpCLYJUM @AJMC_Journal @EBOncology

[Rafael Nadal Fans @RafaelNadalFC]

Congrats @carlosalcaraz 👏👏

[AJMC-Oncology @EBOncology]

Joseph Alvarnas, MD, Discusses New CMS Drug Pricing Models, Impact for Blood Diseases @cityofhope
https://t.co/2Gb2MNoIJd via @AJMC

[AJMC-Oncology @EBOncology]

TPG, AmerisourceBergen Acquire @OneOncology in Deal Valued at $2.1 Billion https://t.co/1MSX8fQlQs via @AJMC

[AJMC-Oncology @EBOncology]

Moderna and Merck’s Cancer Vaccine Cuts Risk of Recurrence or Death 44% in Late-Stage, High-Risk Melanoma After Resection $MRK @AACR https://t.co/tnpwkAgO5n via @AJMC

[AJMC-Oncology @EBOncology]

.@NCCN Session Offers Considerations for Frontline, Second-line Treatment Choices in #CLL https://t.co/eMS0Z8fYyH via @AJMC

[AJMC-Oncology @EBOncology]

Delivery Matters: In Early Studies, DPX Technology Allows Vaccines to Persist When Cancer Pushes Back #IMV #DLBCL #ovarian https://t.co/ZhmHMlqdQO via @AJMC

[AJMC-Oncology @EBOncology]

Delivery Matters: In Early Studies, DPX Technology Allows Vaccines to Persist When Cancer Pushes Back #IMV #DLBCL #ovarian https://t.co/ZhmHMlqdQO via @AJMC

[AJMC-Oncology @EBOncology]

'Live free and die'? The sad state of U.S. life expectancy https://t.co/wHJNnFESzz

[AJMC-Oncology @EBOncology]

What the heck?

[AJMC-Oncology @EBOncology]

Could This Be the Year for #PBM Reform? #COA2023 Panel Weighs in @oncologyCOA @TheUSONetwork @ACCCBuzz https://t.co/0XxhldExXI via @AJMC

[AJMC-Oncology @EBOncology]

Community Oncology Offers Nimbleness for Pivot to Value-Based Care #COA2023 @oncologyCOA https://t.co/pgSuuLrcpx via @AJMC

[AJMC-Oncology @EBOncology]

@AMRaineyMSN Thanks! I very much enjoyed your session and could have written so much more! MKC

[Ted Okon @TedOkonCOA]

BREAKING NEWS: ⁦@SenateFinance⁩ holding hearing 3/30 on #PBM abuses. Panel at #COA2023 now talking #PBMs and their abuses including ⁦@jonlevitt⁩ who will be testifying at the hearing.

[AJMC-Oncology @EBOncology]

As Decision Time on #EOM Nears, Lots of Questions From #COA2023 Panel https://t.co/VbLSwRcjVI via @AJMC

[AJMC-Oncology @EBOncology]

Off to a great start! #COA2023

[Nicolas Ferreyros @nickcf]

RT @TedOkonCOA: Close to 2,000 attendees listening to ⁦@oncologyCOA⁩ co-chairs kicking off the 2023 Community Oncology Conference. #COA2023 Great sessions in a packed agenda.

via @oncologyCOA

[AJMC-Oncology @EBOncology]

Kashyap Patel, MD, Sees Link Between #COVID19 and Cancer Progression, Calls for More #biomarker Testing https://t.co/dvDoERcR2d via @AJMC

[AJMC-Oncology @EBOncology]

Axi-Cel Improves Overall Survival vs Standard-of-Care Initial Treatment for R/R LBCL @KitePharma #Yescarta https://t.co/VuGKfawnXJ via @AJMC